BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36958171)

  • 1. Secondary metabolites as potential drug candidates against Zika virus, an emerging looming human threat: Current landscape, molecular mechanism and challenges ahead.
    Sadeer NB; El Kalamouni C; Khalid A; Abdalla AN; Zengin G; Khoa Bao LV; Mahomoodally MF
    J Infect Public Health; 2023 May; 16(5):754-770. PubMed ID: 36958171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors.
    Gao Y; Tai W; Wang N; Li X; Jiang S; Debnath AK; Du L; Chen S
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of therapeutic and vaccine approaches against Zika virus.
    Wahid B; Ali A; Rafique S; Idrees M
    Eur J Intern Med; 2017 Oct; 44():12-18. PubMed ID: 28797534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Products and Derivatives as Potential
    Pereira RS; Santos FCP; Campana PRV; Costa VV; de Pádua RM; Souza DG; Teixeira MM; Braga FC
    Viruses; 2023 May; 15(5):. PubMed ID: 37243296
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
    Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
    Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors.
    Lima CS; Mottin M; de Assis LR; Mesquita NCMR; Sousa BKP; Coimbra LD; Santos KB; Zorn KM; Guido RVC; Ekins S; Marques RE; Proença-Modena JL; Oliva G; Andrade CH; Regasini LO
    Bioorg Chem; 2021 Apr; 109():104719. PubMed ID: 33636437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targets and biological mechanisms of action of curcumin against Zika virus: In silico and in vitro analyses.
    Kim M; Choi H; Kim YB
    Eur J Pharmacol; 2021 Aug; 904():174144. PubMed ID: 33957087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
    Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
    Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika Virus NS2A-Mediated Virion Assembly.
    Zhang X; Xie X; Xia H; Zou J; Huang L; Popov VL; Chen X; Shi PY
    mBio; 2019 Oct; 10(5):. PubMed ID: 31662457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity against Zika virus of a new formulation of curcumin in poly lactic-co-glycolic acid nanoparticles.
    Pacho MN; Pugni EN; Díaz Sierra JB; Morell ML; Sepúlveda CS; Damonte EB; García CC; D'Accorso NB
    J Pharm Pharmacol; 2021 Mar; 73(3):357-365. PubMed ID: 33793877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol affects Zika virus replication in vitro.
    Mohd A; Zainal N; Tan KK; AbuBakar S
    Sci Rep; 2019 Oct; 9(1):14336. PubMed ID: 31586088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a small compound that specifically inhibits Zika virus in vitro and in vivo by targeting the NS2B-NS3 protease.
    Miao J; Yuan H; Rao J; Zou J; Yang K; Peng G; Cao S; Chen H; Song Y
    Antiviral Res; 2022 Mar; 199():105255. PubMed ID: 35143853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy.
    Chan JF; Zhu Z; Chu H; Yuan S; Chik KK; Chan CC; Poon VK; Yip CC; Zhang X; Tsang JO; Zou Z; Tee KM; Shuai H; Lu G; Yuen KY
    Antiviral Res; 2018 Dec; 160():38-47. PubMed ID: 30326204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosine exhibits significant antiviral activity against Dengue and Zika virus.
    Rothan HA; Abdulrahman AY; Khazali AS; Nor Rashid N; Chong TT; Yusof R
    J Pept Sci; 2019 Aug; 25(8):e3196. PubMed ID: 31290226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
    Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
    J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cathelicidin antimicrobial peptide from Hydrophis cyanocinctus inhibits Zika virus infection by downregulating expression of a viral entry factor.
    Wang J; Jiang B; Wang K; Dai J; Dong C; Wang Y; Zhang P; Li M; Xu W; Wei L
    J Biol Chem; 2022 Oct; 298(10):102471. PubMed ID: 36089062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.